AlzeCure Pharma AB (publ) (FRA:AC6)

Germany flag Germany · Delayed Price · Currency is EUR
0.155
-0.025 (-13.61%)
Last updated: Dec 5, 2025, 8:03 AM CET
106.23%
Market Cap 25.17M
Revenue (ttm) n/a
Net Income (ttm) -3.54M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 1,539
Open 0.156
Previous Close 0.180
Day's Range 0.156 - 0.156
52-Week Range 0.042 - 0.437
Beta n/a
RSI 50.74
Earnings Date Feb 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i... [Read more]

Industry Pharmaceutical Preparations
Founded 2012
Employees 11
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol AC6
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.